The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry

Obesity

Volumn 19, Issue 3, 2011, Pages 624-630

  Shea, Jennifer L ^a,b   Randell, Edward W ^a,b   Sun, Guang ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PHENOTYPE; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FASTING; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; NEWFOUNDLAND AND LABRADOR; OBESITY; PREVALENCE; REFERENCE VALUES; YOUNG ADULT;

EID: 79952006216     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.174     Document Type: Article

References (34)

1. Kim SH, Abbasi F, Reaven GM. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004;27:1998-2002. (Pubitemid 38989245)
2. Dalton M, Cameron AJ, Zimmet PZ et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003;254:555-563. (Pubitemid 37521852)
3. Hu D, Hannah J, Gray RS et al. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study. Obes Res 2000;8:411-421.
4. Saito M, Ishimitsu T, Minami J et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003;167:73-79. (Pubitemid 36255637)
5. Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
6. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 2006;16:513-523. (Pubitemid 44794584)
7. Stefan N, Kantartzis K, Machann J et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-1616.
8. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575. (Pubitemid 38766333)
9. Sims EA. Are there persons who are obese, but metabolically healthy? Metab Clin Exp 2001;50:1499-1504. (Pubitemid 34007425)
10. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214. (Pubitemid 29521852)
11. Kennedy AP, Shea JL, Sun G. Comparison of the Classification of Obesity by BMI vs. Dual-energy X-ray Absorptiometry in the Newfoundland Population. Obesity (Silver Spring) 17:2094-2099.
12. Salamone LM, Fuerst T, Visser M et al. Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol 2000;89:345-352. (Pubitemid 30482598)
13. Curtin F, Morabia A, Pichard C, Slosman DO. Body mass index compared to dual-energy x-ray absorptiometry: evidence for a spectrum bias. J Clin Epidemiol 1997;50:837-843. (Pubitemid 27379795)
14. Lesser GT. Issues in body fatness measurement. Arch Intern Med 2009;169:636.
15. Shea JL, Loredo-Osti JC, Sun G. Association of RBP4 gene variants and serum HDL cholesterol levels in the Newfoundland population. Obesity (Silver Spring) 2010;18:1393-1397.
16. Martin GR, Loredo JC, Sun G. Lack of association of ghrelin precursor gene variants and percentage body fat or serum lipid profiles. Obesity (Silver Spring) 2008;16:908-912. (Pubitemid 351465654)
17. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2008;196:413-419.
18. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 2005;54:3336-3339. (Pubitemid 43334392)
19. Bray GA. Contemporary Diagnosis and Management of Obesity and the Metabolic Syndrome, 3rd edn. Handbooks in Health Care: Newtown, PA, 2003.
20. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
21. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239. (Pubitemid 38924592)
22. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008;34:183-184.
23. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912. (Pubitemid 44271734)
24. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. World Health Organization: Geneva, Switzerland, 1998.
25. Frankenfield DC, Rowe WA, Cooney RN, Smith JS, Becker D. Limits of body mass index to detect obesity and predict body composition. Nutrition 2001;17:26-30. (Pubitemid 32114327)
26. Romero-Corral A, Somers VK, Sierra-Johnson J et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008;32:959-966. (Pubitemid 351986216)
27. Adams TD, Heath EM, LaMonte MJ et al. The relationship between body mass index and per cent body fat in the severely obese. Diabetes Obes Metab 2007;9:498-505. (Pubitemid 47018513)
28. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004;12:887-888. (Pubitemid 41202387)
29. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005;13:1116-1122.
30. Bonora E, Kiechl S, Willeit J et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-1649. (Pubitemid 28445355)
31. Prior BM, Cureton KJ, Modlesky CM et al. In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol 1997;83:623-630. (Pubitemid 27332782)
32. Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150. (Pubitemid 41058189)
33. Esteghamati A, Khalilzadeh O, Anvari M et al. Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 2008;39:803-808.
34. Roubenoff R, Kehayias JJ, Dawson-Hughes B, Heymsfield SB. Use of dual-energy x-ray absorptiometry in body-composition studies: not yet a "gold standard". Am J Clin Nutr 1993;58:589-591.